In addition, rapamycin pre-treatment could reverse the proliferation of HCC cells promoted by CREB3L4, which was featured by decreased cellular viability (Figure 3D) and colony formation (Figure 3E). This evidence concerns the gene CREB3L4 and hepatocellular carcinoma.